Oxidative metabolism of curcumin-glucuronide by peroxidases and isolated human leukocytes

Biochemical Pharmacology

Volumn 132, Issue , 2017, Pages 143-149

  Luis, Paula B ^a   Gordon, Odaine N ^a   Nakashima, Fumie ^b   Joseph, Akil I ^a   Shibata, Takahiro ^b   Uchida, Koji ^b,c   Schneider, Claus ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NAGOYA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Autoxidation; Bicyclopentadione; Curcumin; Glucuronide; Myeloperoxidase; Peroxidase

Indexed keywords

CURCUMIN; GLUCURONIDE; HORSERADISH PEROXIDASE; PEROXIDASE;

AEROBIC METABOLISM; ARTICLE; CATALYSIS; CELL ISOLATION; CONTROLLED STUDY; DRUG CONJUGATION; DRUG METABOLISM; DRUG TRANSFORMATION; HUMAN; HUMAN CELL; LEUKOCYTE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; CELL CULTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; OXIDATION REDUCTION REACTION;

CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMIN; GLUCURONIDES; HUMANS; MASS SPECTROMETRY; OXIDATION-REDUCTION; PEROXIDASES; PROTON MAGNETIC RESONANCE SPECTROSCOPY;

EID: 85014780846     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2017.03.002     Document Type: Article

References (48)

1. [1] Pan, M.H., Huang, T.M., Lin, J.K., Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab. Dispos. 27 (1999), 486–494.
2. [2] Hoehle, S.I., Pfeiffer, E., Metzler, M., Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases. Mol. Nutr. Food Res. 51 (2007), 932–938.
3. [3] Holder, G.M., Plummer, J.L., Ryan, A.J., The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 8 (1978), 761–768.
4. [4] Anand, P., Kunnumakkara, A.B., Newman, R.A., Aggarwal, B.B., Bioavailability of curcumin: problems and promises. Mol. Pharm. 4 (2007), 807–818.
5. [5] Metzler, M., Pfeiffer, E., Schulz, S.I., Dempe, J.S., Curcumin uptake and metabolism. BioFactors 39 (2013), 14–20.
6. [6] Pfeiffer, E., Hoehle, S.I., Walch, S.G., Riess, A., Solyom, A.M., Metzler, M., Curcuminoids form reactive glucuronides in vitro. J. Agric. Food Chem. 55 (2007), 538–544.
7. [7] Hong, J., Bose, M., Ju, J., Ryu, J.H., Chen, X., Sang, S., Lee, M.J., Yang, C.S., Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25 (2004), 1671–1679.
8. [8] Appiah-Opong, R., Commandeur, J.N., van Vugt-Lussenburg, B., Vermeulen, N.P., Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products. Toxicology 235 (2007), 83–91.
9. [9] Shen, L., Ji, H.F., The pharmacology of curcumin: is it the degradation products?. Trends Mol. Med. 18 (2012), 138–144.
10. [10] Griesser, M., Pistis, V., Suzuki, T., Tejera, N., Pratt, D.A., Schneider, C., Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin. J. Biol. Chem. 286 (2011), 1114–1124.
11. [11] Gordon, O.N., Schneider, C., Vanillin and ferulic acid: not the major degradation products of curcumin. Trends Mol. Med. 18 (2012), 361–363 author reply 363–364.
12. [12] Ketron, A.C., Gordon, O.N., Schneider, C., Osheroff, N., Oxidative metabolites of curcumin poison human type II topoisomerases. Biochemistry 52 (2013), 221–227.
13. [13] Pal, A., Sung, B., Bhanu Prasad, B.A., Schuber, P.T. Jr., Prasad, S., Aggarwal, B.B., Bornmann, W.G., Curcumin glucuronides: assessing the proliferative activity against human cell lines. Bioorg. Med. Chem. 22 (2014), 435–439.
14. [14] Shoji, M., Nakagawa, K., Watanabe, A., Tsuduki, T., Yamada, T., Kuwahara, S., Kimura, F., Miyazawa, T., Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells. Food Chem. 151 (2014), 126–132.
15. [15] Ireson, C., Orr, S., Jones, D.J., Verschoyle, R., Lim, C.K., Luo, J.L., Howells, L., Plummer, S., Jukes, R., Williams, M., Steward, W.P., Gescher, A., Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 61 (2001), 1058–1064.
16. [16] Lai, C.S., Wu, J.C., Yu, S.F., Badmaev, V., Nagabhushanam, K., Ho, C.T., Pan, M.H., Tetrahydrocurcumin is more effective than curcumin in preventing azoxymethane-induced colon carcinogenesis. Mol. Nutr. Food Res. 55 (2011), 1819–1828.
17. [17] Wu, J.C., Lai, C.S., Badmaev, V., Nagabhushanam, K., Ho, C.T., Pan, M.H., Tetrahydrocurcumin, a major metabolite of curcumin, induced autophagic cell death through coordinative modulation of PI3K/Akt-mTOR and MAPK signaling pathways in human leukemia HL-60 cells. Mol. Nutr. Food Res. 55 (2011), 1646–1654.
18. [18] Tyagi, N., Qipshidze, N., Munjal, C., Vacek, J.C., Metreveli, N., Givvimani, S., Tyagi, S.C., Tetrahydrocurcumin ameliorates homocysteinylated cytochrome-c mediated autophagy in hyperhomocysteinemia mice after cerebral ischemia. J. Mol. Neurosci. 47 (2012), 128–138.
19. [19] Shen, L., Ji, H.-F., Contribution of degradation products to the anticancer activity of curcumin. Clin. Cancer Res., 15, 2009, 7108.
20. [20] Wang, Y.J., Pan, M.H., Cheng, A.L., Lin, L.I., Ho, Y.S., Hsieh, C.Y., Lin, J.K., Stability of curcumin in buffer solutions and characterization of its degradation products. J. Pharm. Biomed. Anal. 15 (1997), 1867–1876.
21. [21] Gordon, O.N., Luis, P.B., Sintim, H.O., Schneider, C., Unraveling curcumin degradation. Autoxidation proceeds through spiroepoxide and vinylether intermediates en route to the main bicyclopentadione. J. Biol. Chem. 290 (2015), 4817–4828.
22. [22] Schneider, C., Gordon, O.N., Edwards, R.L., Luis, P.B., Degradation of curcumin: from mechanism to biological implications. J. Agric. Food Chem. 63 (2015), 7606–7614.
23. [23] Pabon, H.J.J., A synthesis of curcumin and related compounds. Recl. Trav. Chim. Pays-Bas 83 (1964), 379–386.
24. [24] Gordon, O.N., Graham, L.A., Schneider, C., Facile synthesis of deuterated and [(14) C]labeled analogs of vanillin and curcumin for use as mechanistic and analytical tools. J. Labelled Comp. Radiopharm. 56 (2013), 696–699.
25. [25] Moon, J.H., Tsushida, T., Nakahara, K., Terao, J., Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic. Biol. Med. 30 (2001), 1274–1285.
26. [26] Rooseboom, M., Commandeur, J.N., Vermeulen, N.P., Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol. Rev. 56 (2004), 53–102.
27. [27] Thompson, D., Constantin-Teodosiu, D., Norbeck, K., Svensson, B., Moldeus, P., Metabolic activation of eugenol by myeloperoxidase and polymorphonuclear leukocytes. Chem. Res. Toxicol. 2 (1989), 186–192.
28. [28] Ortiz de Montellano, P.R., David, S.K., Ator, M.A., Tew, D., Mechanism-based inactivation of horseradish-peroxidase by sodium-azide – formation of meso-azidoprotoporphyrin-IX. Biochemistry 27 (1988), 5470–5476.
29. [29] Litwinienko, G., Ingold, K.U., Abnormal solvent effects on hydrogen atom abstraction. 2. Resolution of the curcumin antioxidant controversy. The role of sequential proton loss electron transfer. J. Org. Chem. 69 (2004), 5888–5896.
30. [30] Litwinienko, G., Ingold, K.U., Solvent effects on the rates and mechanisms of reaction of phenols with free radicals. Acc. Chem. Res. 40 (2007), 222–230.
31. [31] Gordon, O.N., Luis, P.B., Ashley, R.E., Osheroff, N., Schneider, C., Oxidative transformation of demethoxy- and bisdemethoxycurcumin: products, mechanism of formation, and poisoning of human topoisomerase IIalpha. Chem. Res. Toxicol. 28 (2015), 989–996.
32. [32] Soares, C.H.L., Bechara, E.J.H., Enzymatic generation of triplet biacetyl. Photochem. Photobiol. 36 (1982), 117–119.
33. [33] Masuda, T., Hidaka, K., Shinohara, A., Maekawa, T., Takeda, Y., Yamaguchi, H., Chemical studies on antioxidant mechanism of curcuminoid: analysis of radical reaction products from curcumin. J. Agric. Food Chem. 47 (1999), 71–77.
34. [34] Esparan, V., Krings, U., Struch, M., Berger, R.G., A three-enzyme-system to degrade curcumin to natural vanillin. Molecules 20 (2015), 6640–6653.
35. [35] Klebanoff, S.J., Myeloperoxidase: friend and foe. J. Leukoc. Biol. 77 (2005), 598–625.
36. [36] Thompson, D., Norbeck, K., Olsson, L.I., Constantin-Teodosiu, D., Van der Zee, J., Moldeus, P., Peroxidase-catalyzed oxidation of eugenol: formation of a cytotoxic metabolite(s). J. Biol. Chem. 264 (1989), 1016–1021.
37. [37] Lobach, A.R., Uetrecht, J., Involvement of myeloperoxidase and NADPH oxidase in the covalent binding of amodiaquine and clozapine to neutrophils: implications for drug-induced agranulocytosis. Chem. Res. Toxicol. 27 (2014), 699–709.
38. [38] Davies, M.J., Hawkins, C.L., Pattison, D.I., Rees, M.D., Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid. Redox Signal. 10 (2008), 1199–1234.
39. [39] Bafort, E., Parisi, O., Perraudin, J.P., Jijakli, M.H., Mode of action of lactoperoxidase as related to its antimicrobial activity: a review. Enzyme Res., 2014 Article ID 517164.
40. [40] Ramsden, C.A., Riley, P.A., Tyrosinase: the four oxidation states of the active site and their relevance to enzymatic activation, oxidation and inactivation. Bioorg. Med. Chem. 22 (2014), 2388–2395.
41. [41] Rao, C.V., Regulation of COX and LOX by curcumin. Adv. Exp. Med. Biol. 595 (2007), 213–226.
42. [42] Nishino, T., Okamoto, K., Eger, B.T., Pai, E.F., Nishino, T., Mammalian xanthine oxidoreductase – mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J. 275 (2008), 3278–3289.
43. [43] Lin, J.K., Shih, C.A., Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3T3 cells. Carcinogenesis 15 (1994), 1717–1721.
44. [44] Pauff, J.M., Hille, R., Inhibition studies of bovine xanthine oxidase by luteolin, silibinin, quercetin, and curcumin. J. Nat. Prod. 72 (2009), 725–731.
45. [45] Boersma, M.G., Vervoort, J., Szymusiak, H., Lemanska, K., Tyrakowska, B., Cenas, N., Segura-Aguilar, J., Rietjens, I.M., Regioselectivity and reversibility of the glutathione conjugation of quercetin quinone methide. Chem. Res. Toxicol. 13 (2000), 185–191.
46. [46] Awad, H.M., Boersma, M.G., Boeren, S., Van Bladeren, P.J., Vervoort, J., Rietjens, I.M., Quenching of quercetin quinone/quinone methides by different thiolate scavengers: stability and reversibility of conjugate formation. Chem. Res. Toxicol. 16 (2003), 822–831.
47. [47] Mathews, S., Rao, M.N.A., Interaction of curcumin with glutathione. Int. J. Pharm. 76 (1991), 257–259.
48. [48] Awasthi, S., Pandya, U., Singhal, S.S., Lin, J.T., Thiviyanathan, V., Seifert, W.E., Awasthi, Y.C., Ansari, G.A.S., Curcumin-glutathione interactions and the role of human glutathione S-transferase P1–1. Chem. Biol. Interact. 128 (2000), 19–38.